{"id":"NCT01260883","sponsor":"Seattle Children's Hospital","briefTitle":"Ketorolac in Postoperative Infants: Pharmacokinetics and Safety","officialTitle":"Ketorolac in Postoperative Infants: Pharmacokinetics and Safety","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2000-05","primaryCompletion":"2008-03","completion":"2010-12","firstPosted":"2010-12-15","resultsPosted":"2012-08-08","lastUpdate":"2013-06-13"},"enrollment":77,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Postoperative Pain in Infants"],"interventions":[{"type":"DRUG","name":"Ketorolac Tromethamine 1 mg/kg","otherNames":["toradol"]},{"type":"DRUG","name":"Ketorolac Tromethamine 0.5 mg/kg","otherNames":["toradol"]},{"type":"DRUG","name":"Placebo","otherNames":["Dextrose in water (D5W)"]}],"arms":[{"label":"ketorolac 1 mg/kg","type":"EXPERIMENTAL"},{"label":"ketorolac 0.5 mg/kg","type":"ACTIVE_COMPARATOR"},{"label":"placebo","type":"SHAM_COMPARATOR"}],"summary":"Infants handle ketorolac differently than adults. Study of handling of this pain medication given to infants following surgery. Detailed analysis of how the drug is eliminated from age 2 months to 18 months. Compared morphine use in infants who received the drug to the group getting placebo. Safety testing for kidney and liver function, breathing measured by continuous oximetry, and any bleeding issues.","primaryOutcome":{"measure":"Clearance of S-ketorolac and R+ Ketorolac in 2-6 Month Old Infants Following Surgery","timeFrame":"24 hours following surgery","effectByArm":[{"arm":"S- Ketorolac Clearance","deltaMin":30.7,"sd":22.8},{"arm":"R+ Ketorolac Clearance","deltaMin":6.5,"sd":2.2}],"pValues":[]},"eligibility":{"minAge":"2 Months","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":5},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["17456651","21199130"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":22},"commonTop":[]}}